Literature DB >> 22846955

"SCIP"ping antibiotic prophylaxis guidelines in trauma: The consequences of noncompliance.

Brian P Smith1, Nicole Fox, Abdulla Fakhro, Mary LaChant, Abhijit S Pathak, Steven E Ross, Mark J Seamon.   

Abstract

OBJECTIVE: The Surgical Care Improvement Project (SCIP) established surgical antibiotic prophylaxis guidelines as part of a national patient safety initiative aimed at reducing surgical complications such as surgical site infection (SSI). Although these antibiotic prophylaxis guidelines have become well established in surgical patients, they remain largely unstudied in patients with injury from trauma undergoing operative procedures. We sought to determine the role of these antibiotic prophylaxis guidelines in preventing SSI in patients undergoing trauma laparotomy.
METHODS: A retrospective review of all patients who underwent emergency trauma laparotomy at two Level I trauma centers (2007-2008) revealed 306 patients who survived more than 4 days after injury. Demographics and clinical risk SSI factors were analyzed, and patients were compared on the basis of adherence to the following SCIP guidelines: (1) prophylactic antibiotic given, (2) antibiotic received within 1 hour before incision, (3) correct antibiotic selection, and (4) discontinuation of antibiotic within 24 hours after surgery. The primary study end point was the development of SSI.
RESULTS: The study sample varied by age (mean [SD], 32 [16] years) and injury mechanism (gunshot wound 44%, stab wound 27%, blunt trauma 30%). When patients with perioperative antibiotic management complying with the four SCIP antibiotic guidelines (n = 151) were compared with those who did not comply (n = 155), no difference between age, shock, small bowel or colon resection, damage control procedures, and skin closure was detected (p > 0.05). After controlling for injury severity score, hypotension, blood transfusion, enteric injury, operative duration, and other potential confounding variables in a multivariate analysis, complete adherence to these four SCIP antibiotic guidelines independently decreased the risk of SSI (odds ratio, 0.43; 95% confidence interval, 0.20-0.94; p = 0.035). Patients adhering to these guidelines less often developed SSI (17% vs. 33%, p = 0.001) and had shorter overall hospital duration of antibiotics (4 [6] vs. 9 [11] days, p < 0.001) and hospital length of stay (14 [13] vs. 19 [23] days, p = 0.016), although no difference in mortality was detected (p > 0.05).
CONCLUSIONS: Our results suggest that SCIP antibiotic prophylaxis guidelines effectively reduce the risk of SSI in patients undergoing trauma laparotomy. Despite the emergent nature of operative procedures for trauma, efforts to adhere to these antibiotic guidelines should be maintained.

Entities:  

Mesh:

Year:  2012        PMID: 22846955     DOI: 10.1097/TA.0b013e31825ff670

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  12 in total

1.  Improving trauma care in low- and middle-income countries by implementing a standardized trauma protocol.

Authors:  Matthew Ryan Kesinger; Juan Carlos Puyana; Andres M Rubiano
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  Predictors of Postoperative Urinary Tract Infection After Bariatric Surgery.

Authors:  Zachary M Helmen; Melissa C Helm; Joseph H Helm; Alexander Nielsen; Tammy Kindel; Rana Higgins; Jon C Gould
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

3.  Management and Outcomes of Acute Surgical Patients at a District Hospital in Uganda with Non-physician Emergency Clinicians.

Authors:  Caleb Dresser; Usha Periyanayagam; Brad Dreifuss; Robert Wangoda; Julius Luyimbaazi; Mark Bisanzo
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

4.  Antimicrobial Prophylaxis Redosing Reduces Surgical Site Infection Risk in Prolonged Duration Surgery Irrespective of Its Timing.

Authors:  Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

5.  Variation in Postinjury Antibiotic Prophylaxis Patterns Over Five Years in a Combat Zone.

Authors:  Bradley A Lloyd; Clinton K Murray; William Bradley; Faraz Shaikh; Deepak Aggarwal; M Leigh Carson; David R Tribble
Journal:  Mil Med       Date:  2017-03       Impact factor: 1.437

6.  The influence of the risk factor on the abdominal complications in colon injury management.

Authors:  M Torba; A Gjata; S Buci; G Bushi; A Zenelaj; I Kajo; S Koceku; K Kagjini; K Subashi
Journal:  G Chir       Date:  2015 Mar-Apr

7.  Adherence to published antimicrobial prophylaxis guidelines for wounded service members in the ongoing conflicts in Southwest Asia.

Authors:  Bradley A Lloyd; Amy C Weintrob; Mary K Hinkle; Gerald R Fortuna; Clinton K Murray; William Bradley; Eugene V Millar; Faraz Shaikh; Kristen Vanderzant; Stacie Gregg; Gina Lloyd; Julie Stevens; M Leigh Carson; Deepak Aggarwal; David R Tribble
Journal:  Mil Med       Date:  2014-03       Impact factor: 1.437

8.  Risk Factors for Surgical Site Infections in Patients Undergoing Emergency Surgery: A Single-centre Experience.

Authors:  Aristeidis Papadopoulos; Nikolaos Machairas; Gerasimos Tsourouflis; Christos Chouliaras; Eleni Manioti; Dimitrios Broutas; Stylianos Kykalos; George L Daikos; Michael Samarkos; Constantine Vagianos
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 9.  Prolonged Operative Duration Increases Risk of Surgical Site Infections: A Systematic Review.

Authors:  Hang Cheng; Brian Po-Han Chen; Ireena M Soleas; Nicole C Ferko; Chris G Cameron; Piet Hinoul
Journal:  Surg Infect (Larchmt)       Date:  2017 Aug/Sep       Impact factor: 2.150

10.  Impact of bodyweight-adjusted antimicrobial prophylaxis on surgical-site infection rates.

Authors:  L Salm; W R Marti; D J Stekhoven; C Kindler; M Von Strauss; E Mujagic; W P Weber
Journal:  BJS Open       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.